Key Financial Data Of Group

Oncolys BioPharma Inc. - Filing #7733573

Concept As at
2017-09-30
2017-07-01 to
2017-09-30
2017-01-01 to
2017-09-30
As at
2016-12-31
2016-01-01 to
2016-12-31
2016-07-01 to
2016-09-30
As at
2016-09-30
2016-01-01 to
2016-09-30
Key financial data of group
Business results of group
Net sales
29,027,000 JPY
178,313,000 JPY
46,540,000 JPY
Ordinary profit (loss)
-776,782,000 JPY
-864,241,000 JPY
-682,662,000 JPY
Net assets
3,165,334,000 JPY
2,617,383,000 JPY
2,746,373,000 JPY
Total assets
3,775,634,000 JPY
3,140,313,000 JPY
3,231,018,000 JPY
Basic earnings (loss) per share
-24.18
-77.81
-101.18
-33.99
-79.53
Diluted earnings per share
Equity-to-asset ratio
0.835 xbrli:pure
0.827 xbrli:pure
0.848 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.